Literature DB >> 824399

Histaminase release from human granulocytes.

R S Zeiger, F J Twarog, H R Colten.   

Abstract

Histaminase (EC-1.4.3.6), one of the two catabolic enzymes for histamine, is contained in human granulocytes. Opsonized zymosan or the calcium ionophore A-23187 induce a dose-dependent release of histaminase from human granulocytes in vitro. Release is completed within 30 min, is temperature dependent, and requires divalent cations. Opsonized zymosan-induced histaminase release was maximal in the presence of both calcium and magnesium, whereas ionophore release was magnesium independent. The total cellular content of histaminase could be released by both opsonized zymosan and ionophore. In contrast, only 25% of the cellular beta glucuronidase, a lysosomal enzyme, was released after maximal stimulation with opsonized zymosan; there was minimal release of beta glucuronidase with ionophore. Zymosan- and ionophore-induced histaminase release was inhibited by agents that are presumed to interfere with cell metabolism and disrupt microtubules. Human granulocytes therefore may modulate the effect of histamine by releasing histaminase at a site of inflammation. Studies of granulocyte histaminase release in vitro may also provide a new model to explore granulocyte function and secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824399      PMCID: PMC2190434          DOI: 10.1084/jem.144.4.1049

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Catabolism of physiological quantities of histamine in vivo.

Authors:  R W SCHAYER
Journal:  Physiol Rev       Date:  1959-01       Impact factor: 37.312

2.  Calcium-induced insulin release in monolayer culture of the endocrine pancreas. Studies with ionophore A23187.

Authors:  C B Wollheim; B Blondel; P A Trueheart; A E Renold; G W Sharp
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

3.  Histamine metabolism. I. Thin-layer radiochromatographic assays for histaminase and histidine decarboxylase enzyme activities.

Authors:  R S Zeiger; D L Yurdin; F J Twarog
Journal:  J Lab Clin Med       Date:  1976-06

4.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

5.  Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes.

Authors:  I M Goldstein; J K Horn; H B Kaplan; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

6.  Dual effect of lanthanum on histamine release from mast cells.

Authors:  J C Foreman; J L Mongar
Journal:  Nat New Biol       Date:  1972-12-20

7.  The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.

Authors:  L M Lichtenstein; R DeBernardo
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

8.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

9.  Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis.

Authors:  A T Davis; R Estensen; P G Quie
Journal:  Proc Soc Exp Biol Med       Date:  1971-05

10.  The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

Authors:  D F Bainton; J L Ullyot; M G Farquhar
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  11 in total

1.  Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Authors:  Y Raab; K Fredens; B Gerdin; R Hällgren
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

2.  Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.

Authors:  W König; N Frickhofen; H Tesch
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

3.  Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.

Authors:  T Seya; S Nagasawa; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).

Authors:  M A Arnaout; R F Todd; N Dana; J Melamed; S F Schlossman; H R Colten
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Complement-dependent histaminase release from human granulocytes.

Authors:  J J Herman; I K Rosner; A E Davis; R S Zeiger; M A Arnaout; H R Colten
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

6.  Localization of histaminase to the specific granule of the human neutrophil.

Authors:  E W Ringel; N A Soter; K F Austen
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

7.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

8.  Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein.

Authors:  R Hällgren; N Feltelius; K Svenson; P Venge
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  Effects of proteoglycan on dextran sulfate sodium-induced experimental colitis in rats.

Authors:  Sakae Ota; Shuichi Yoshihara; Keinosuke Ishido; Masanori Tanaka; Keiichi Takagaki; Mutsuo Sasaki
Journal:  Dig Dis Sci       Date:  2008-05-08       Impact factor: 3.199

10.  Presence and measurement of tele-methylhistamine in mast cells.

Authors:  R C Goldschmidt; J K Khandelwal; L B Hough
Journal:  Agents Actions       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.